Valuation: Inhalation Sciences Sweden AB

Market Cap	9.47M 998K 865K 806K 741K 1.4M 94.93M 1.42M 3.72M 47.5M 3.75M 3.67M 157M	P/E 2024	-12.8x	P/E 2025	-12.4x
Enterprise Value	6.64M 700K 606K 565K 520K 981K 66.55M 992K 2.61M 33.3M 2.63M 2.57M 110M	EV / Sales 2024	5.6x	EV / Sales 2025	55x
Free-Float	94.25%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Inhalation Sciences Sweden AB

Dynamic Chart

Latest news : Inhalation Sciences Sweden AB

29/07	Inhalation Sciences secures financing of up to €0.4m	FW
16/06	Inhalation Sciences Secures SEK 0.4m Research Grant	FW
29/05	Inhalation Sciences continues to evaluate sale – issues fresh warning over funding shortfall	FW
27/05	Inhalation Sciences working to secure additional funding	FW
18/05	Inhalation Sciences Sweden Wins Inhalation Research Services Order	MT
18/05	Inhalation Sciences secures order worth approximately SEK 1.3 million	FW
18/05	Inhalation Sciences Sweden AB Receives IRS Order Worth Approximately EUR 117,000	CI
11/05	Inhalation Sciences posts revenue and order intake growth in Q1	FW
11/05	Inhalation Sciences Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
25/03	Inhalation Sciences secures order worth SEK 350,000	FW
25/03	Inhalation Sciences Sweden AB Secures Additional PreciseInhale Service Orders Worth SEK 350,000	CI
03/03	Inhalation Sciences Raises SEK 2.88 Million Through Warrant Exercise and Directed Share Issue	FW
27/02	Inhalation Sciences Sees Decline in Revenue and Operating Profit – Starts 2026 with Strong Order Backlog	FW

More news

Press Releases: Inhalation Sciences Sweden AB

18/05	Inhalation Sciences receives IRS order worth approximately EUR 117,000	AQ
25/03	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	PU
25/03	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	AQ
18/02	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000	AQ
27/01	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies	PU

More press releases

Managers and Directors: Inhalation Sciences Sweden AB

Manager	Title	Age	Since
Manoush Masarrat CEO	Chief Executive Officer	-	16/09/2019
Per Magnus Gerde CTO	Chief Tech/Sci/R&D Officer	-	01/01/2005
Ulf Wedenberg PRN	Corporate Officer/Principal	-	02/06/2025

Director	Title	Age	Since
Per Magnus Gerde BRD	Director/Board Member	-	01/01/2005
Jan Hellqvist BRD	Director/Board Member	-	01/09/2022
Ulf Ericsson BRD	Director/Board Member	-	01/09/2024

More insiders

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INHALATION SCIENCES SWEDEN AB	-1.07%	-15.91%	-95.74%	-93.62%	992K
THERMO FISHER SCIENTIFIC, INC.	+1.92%	-0.05%	+23.54%	+4.42%	209B
DANAHER CORPORATION	+1.79%	+1.14%	-0.16%	-22.26%	137B
INTUITIVE SURGICAL, INC.	+1.74%	+6.02%	-21.52%	+21.06%	130B
BOSTON SCIENTIFIC CORPORATION	-3.84%	+2.55%	-54.96%	-6.93%	71.14B
EDWARDS LIFESCIENCES CORPORATION	-0.99%	+3.54%	+12.06%	+11.22%	51.59B
SIEMENS HEALTHINEERS AG	+0.62%	+4.53%	-14.27%	-19.57%	49.99B
AGILENT TECHNOLOGIES, INC.	+1.11%	+0.42%	+22.63%	+11.36%	39.31B
WATERS CORPORATION	+0.85%	+5.49%	+42.36%	+38.17%	38.89B
RESMED, INC.	-0.47%	+3.83%	-21.93%	+19.19%	32.19B
Average	+0.14%	+1.28%	-10.80%	-3.70%	75.9B
Weighted average by Cap.	+0.83%	+1.42%	-0.10%	+2.99%

See all sector performances

Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Companyâ€™s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Companyâ€™s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Companyâ€™s main shareholder is Nordnet Pensionsforsakring.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

24/08 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
04/08/26	SEK 0.1850	-1.07%	87
03/08/26	SEK 0.1870	+3.89%	19,325
31/07/26	SEK 0.1800	-16.67%	370,147
29/07/26	SEK 0.2160	-1.82%	248,550
28/07/26	SEK 0.2200	-3.08%	1,027

End-of-day quote SPOTLIGHT STOCK MARKET AB

More quotes

Income Statement and Estimates

More financial data

Net sales - Rate of surprise

Company calendar

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

1 day	-1.07%
1 week	-15.91%
Current month	+2.78%
1 month	-21.61%
3 months	-24.49%
6 months	-46.22%
Current year	-95.74%

1 week	0.18	0.21
1 month	0.18	0.25
Current year	0.17	0.58
1 year	0.17	0.58
3 years	0.17	4.99
5 years	0.17	11.3
10 years	0.17	15.48

	2024	2025
Net sales	11.05M 1.16M 1.01M 940K 865K 1.63M 111M 1.65M 4.34M 55.4M 4.37M 4.28M 183M	3.04M 321K 278K 259K 238K 449K 30.48M 454K 1.19M 15.25M 1.2M 1.18M 50.51M
Net income	-5.15M -543K -470K -438K -403K -761K -51.59M -769K -2.02M -25.81M -2.04M -1.99M -85.48M	-10.16M -1.07M -927K -865K -795K -1.5M -102M -1.52M -3.99M -50.95M -4.02M -3.93M -169M
Net Debt	-4M -422K -365K -341K -313K -591K -40.12M -598K -1.57M -20.07M -1.58M -1.55M -66.48M	-2.83M -298K -258K -241K -222K -418K -28.37M -423K -1.11M -14.2M -1.12M -1.1M -47.02M

Inhalation Sciences Sweden AB Stock

Stocks

ISAB

SE0009983893